|
|
Article: BWR Begins Tracking Targeted Genetics Corporation.
- Article from:
- M2 Presswire
- Article date:
- June 4, 2007
CopyrightCOPYRIGHT 2007 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-4 June 2007-Biotech News: BWR Begins Tracking Targeted Genetics Corporation(C)1994-2007 M2 COMMUNICATIONS LTD
RDATE:04062007
Targeted Genetics is putting the bull's-eye on disease. The firm is developing gene therapy products to treat acquired and inherited diseases. Gene therapy involves the insertion of genes into cells to produce proteins necessary in addressing certain disease conditions. The firm concentrates its efforts on adeno-associated viral (AAV) vectors, which deliver genetic material to cells, for treating various diseases and conditions. Its lead AAV candidates, which are in clinical trials, target HIV/AIDS and rheumatoid ...